October, 2025
October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Anticoagulants and Immunosuppressives in Behçet’s Syndrome
Oct 22, 2025, 04:29

Anticoagulants and Immunosuppressives in Behçet’s Syndrome

Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:

”Anticoagulants and immunosuppressive therapy for thrombosis in Behçet’s syndrome: a systematic review and meta-analysis
By Arisa Chuklin, Thita Joy Chiasakul, and Noppacharn Uaprasert

• Context: Behçet’s syndrome is a systemic vasculitis often complicated by venous or arterial thrombosis, yet the optimal role of anticoagulation remains uncertain.
• Study: Across 20 studies (315 patients with disaggregated data), this meta-analysis compared relapse rates under immunosuppressives, anticoagulants, or both.
• Findings: Combination therapy markedly reduced thrombosis relapse (17.7%) versus immunosuppressives alone (43.7%) or anticoagulants alone (54.9%), supporting a dual-modality approach for vascular Behçet’s.”

Title: Anticoagulants and immunosuppressive therapy for thrombosis in Behçet’s syndrome: a systematic review and meta-analysis

Authors: Arisa Chuklin, Thita Chiasakul, Noppacharn Uaprasert

Anticoagulants

Read the article here.

Stay updated on all scientific advances with Hemostasis Today.